Lonza’s Bioscience division, consisting of its Cell Therapy, Rapid Testing Systems, Media, and Cell Discovery and Molecular Biology businesses, reported CHF 82 million ($66.9 million) in sales and EBIT of CHF 12 million ($9.8 million) for the first half of 2007. Media, and Cell Discovery and Molecular Biology sales were lower than expected. CellSystems Biotechnologies […]
In the third quarter of 2007, revenues for IBO’s Laboratory Instrument Sales Index grew an impressive 13.7% to $4,218 million, identical to the second quarter’s revenue growth. Operating profit grew 21.8% to $693 million, and operating margin climbed 110 basis points to 16.4% of sales. Strong organic growth, acquisitions and favorable currency effects continued to […]
The Society for Biomolecular Sciences’ (SBS) Symposium, “Back to Pharmacology: Stem Cells and Primary Cells in Drug Discovery,” was held on November 8 and 9 at the Anaheim Marriott Hotel in Anaheim, California. It was one of SBS’ small symposia focused on specific topics that the organization has been holding for a number of years […]
Arlington, Virginia 11/7/07—Security technologies company ICx Technologies completed its IPO to raise $80 million (see IBO 8/15/07). The company sold five million shares of common stock on the NASDAQ stock exchange at $16 per share. Earlier this month, the company had forecasted a price of $17–$19 per share. Shares fell 19% in their first week […]
Spurred by the likelihood of rising fuel demand in developing economies and increasingly stringent regulations for carbon dioxide emissions in developed economies, several of the leading oil producers have been investing heavily in partnerships with universities for biofuel research. The most substantial of these investments is $500 million from BP for a 10-year consortium among […]
The US-China Business Council’s (USCBC) 2007 Member Priorities Survey reflects a mood of optimism. Eighty-three percent of the respondents stated that their operations in China were profitable and two-thirds said that the profitability rate of their Chinese operations is equal to or higher than their companies’ global rate. Ninety-two percent of respondents expect sales increases […]
West Chester, PA 11/6/07—VWR International has purchased Omnilabo BV, a Netherlands-based distributor of laboratory products, from private equity firm Nimbus. Founded in 1979, Omnilabo has 42 employees based in the Netherlands and Belgium. “The acquisition of Omnilabo is a great fit with our Dutch and European distribution operations,” said Manuel Brocke-Benz, senior vice president and […]
Santa Clara, CA 11/7/07—Agilent Technologies has definitively agreed to purchase Velocity11, a provider of liquid handling and laboratory robotics for the life science market. Financial terms were not disclosed. “Velocity11 is a market leader in lab automation with a solid reputation for innovative technology, quality products and superb customer service,” commented Nick Roelofs, vice president […]
Nuclear magnetic resonance (NMR) is considered one of the “big guns” of the analytical instrument industry, with annual sales rapidly approaching the $1 billion mark. While one may be impressed by the sheer size of NMR systems with high-strength magnets, the probe, which provides the means to interface the sample with the instrument, is an […]
Thermo Fisher Scientific launched the TurboTox GC/MS Productivity Solution for drugs of abuse testing. It consists of the DSQ II single quadrupole GC/MS, ToxLab 2.0 software, and methods and consumables. AC Analytical Controls introduced the AC All in One Biodiesel analyzer, featuring an Agilent 7890A GC. Phenomenex introduced Zebron ZB-5Msi GC columns for separation of […]
Pay Invoice
Latest Blogs
-
LAUDA: Temperature Control Innovation
December 10, 2024 4:11 pm
-
Perseverance Forecasted for the Pharmaceutical Market for Analytical and Scientific Instrumentation
October 24, 2024 5:17 pm
-
M&A Activity in the Analytical Instrumentation and Lab Tools Market. 2021-2023
September 30, 2024 1:32 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
